When to Stop Biotin Before a Thyroid Test?

The American Thyroid Association recommends stopping biotin supplements at least two days before any thyroid blood test. That two-day window is the widely cited minimum, but the reality is messier: people taking high doses of biotin, particularly the mega-doses sometimes prescribed for multiple sclerosis, may need considerably longer for their levels to clear enough to avoid distorted results. Biotin doesn’t change how your thyroid actually functions. It fools the lab equipment, creating numbers that can look like a thyroid disorder where none exists.

Why Biotin Fools Thyroid Lab Equipment

Most thyroid blood tests run on automated platforms that rely on a chemical pairing called biotin-streptavidin. Streptavidin has an extraordinarily strong grip on biotin, and lab manufacturers exploit that grip to anchor key reagents during a test. When you have extra biotin floating in your blood from a supplement, it competes with the biotin that’s supposed to be doing work inside the assay. The result is a signal that no longer reflects your actual hormone levels.

Depending on the specific design of the test, biotin interference can produce either falsely high or falsely low values. In competitive assays, which measure smaller molecules like free T4 and free T3, the interference tends to push results falsely upward. In sandwich assays, which measure larger molecules like TSH, the interference tends to push results falsely downward. That combination is especially deceptive: high free T4 paired with low TSH looks exactly like hyperthyroidism or Graves’ disease on paper, even in someone whose thyroid is perfectly normal.

What the Distorted Numbers Actually Look Like

In healthy adults given biotin supplements, researchers found statistically significant false increases in total T3, free T3, and free T4 on Roche cobas platforms, and in free T3 on Siemens Vista Dimension equipment.¹ Meanwhile, TSH readings get suppressed. That pattern mimics an overactive thyroid so convincingly that clinicians have initiated treatment for Graves’ disease based entirely on lab values caused by biotin interference.

In one striking case series, four patients taking 20 to 30 milligrams of biotin daily showed misleading increases in thyroid function tests that pointed toward a false diagnosis of Graves’ disease.² A separate case involved a patient on high-dose biotin for progressive multiple sclerosis whose free T4 came back above 7.8 ng/dL, more than four times the upper limit of normal, while TSH registered at essentially zero. When biotin was stopped and the tests were repeated, everything came back normal.³ The patient’s thyroid had been fine the whole time.

The Two-Day Minimum and When It Falls Short

The American Thyroid Association’s recommendation to stop biotin at least two days before lab work is based on biotin’s relatively short half-life in the blood. For most people taking typical supplement doses, two days is enough for blood levels to drop below the threshold where interference becomes clinically meaningful.⁴ Clinicians are advised to tell patients to hold biotin for at least this long before any blood draw.⁵

But two days is a floor, not a guarantee. In a case report of a patient taking high-dose biotin for multiple sclerosis, thyroid test results normalized only after biotin was withheld for a full week.⁶ In another case, a woman on 10 milligrams of biotin twice daily had confusing, fluctuating thyroid results for an extended period until clinicians finally identified biotin as the culprit and held the supplement, after which her labs made sense and her levothyroxine dose was easily optimized.⁷

If you’re taking a standard over-the-counter biotin dose for hair or nails, the two-day guideline is reasonable. If you’re on anything above a few milligrams daily, or certainly if you’re on the therapeutic mega-doses used for neurological conditions, a longer washout period is prudent. Some practitioners suggest at least a week for high-dose users, though there’s no formal guideline pinning down the exact number of days for every dose level.

Low-Dose Supplements Are a Smaller Problem, but Not Zero

The recommended daily intake of biotin sits in the range of 30 to 70 micrograms. Many hair, skin, and nail supplements contain 2,500 to 10,000 micrograms per tablet, which is already many times the recommended intake but still far below the mega-doses used in multiple sclerosis treatment (up to 300 milligrams, or 300,000 micrograms, daily).⁶

A study looking specifically at patients taking low-dose biotin supplements (under 300 micrograms per day) found that after those supplements were discontinued, there was a statistically significant increase in TSH and decline in free T4. The effect was real but clinically minor: it led to a medication dose change in only about 3.5 percent of the patients studied.⁸ That’s worth knowing: even low-dose supplements can nudge your numbers, but for most people at those doses the effect probably won’t send you down the wrong treatment path. At higher doses, the stakes rise sharply.

Kidney Disease Makes the Problem Worse

Biotin is cleared through the kidneys. When kidney function is impaired, biotin hangs around in the blood longer and accumulates to higher concentrations. Two documented cases of patients with chronic kidney failure showed seriously misleading thyroid and parathyroid function test results due to biotin interference.⁹ The combination of reduced kidney clearance and even modest biotin supplementation can push blood levels well into the range where assay interference is substantial.

If you have chronic kidney disease and take any amount of biotin, the standard two-day washout may not be enough. Your doctor should know about the supplement so they can plan accordingly, whether that means extending the washout period, choosing a different assay platform, or having the lab take additional steps to check for interference.

It’s Not Just Thyroid Tests

Biotin-streptavidin technology is used in many immunoassays beyond thyroid panels. A comprehensive assessment of biotin interference across multiple test types found that the most notable false reductions occurred in high-sensitivity troponin T, TSH, and follicle-stimulating hormone, while the most notable false increases appeared in triiodothyronine and vitamin D results.¹⁰ The troponin finding is especially alarming. Troponin is the blood test emergency doctors use to determine whether someone is having a heart attack. The FDA has documented a patient death linked to a falsely low troponin result caused by supraphysiologic biotin intake.¹¹

If your doctor has ordered a broader panel of blood work, the biotin washout applies to all of it, not just thyroid-specific tests. Fertility hormones, vitamin D levels, cardiac markers, and several other analytes can all be affected.¹²

Not All Lab Platforms Are Equally Vulnerable

The interference problem is specific to assays that use the biotin-streptavidin linkage. Not every lab platform does. Abbott’s Architect system, for example, uses a magnetic bead–based capture method instead. Manufacturer data indicate no interference with biotin concentrations up to 1,000 micrograms per liter on that platform.¹³ If your lab happens to run your thyroid panel on a platform that doesn’t use biotin-streptavidin chemistry, your results won’t be affected regardless of what you’re taking.

Manufacturers have also been working on updated versions of their vulnerable assays. A study evaluating new-generation Roche electrochemiluminescent immunoassays for TSH found that the previous generation was affected by biotin concentrations as low as about 40 ng/mL, while the new generation tolerated concentrations up to 1,200 ng/mL without interference.¹⁴ That’s a dramatic improvement, and it suggests this problem will gradually become less common as labs upgrade equipment. But “gradually” is the key word. Many labs are still running older platforms, and you typically won’t know which generation of assay is being used on your blood sample.

A separate study using Beckman analyzers identified the threshold for biotin interference in thyroid tests at 25 ng/mL on that platform.¹⁵ Different platforms have different vulnerability thresholds, and those thresholds are low enough that supplement-level doses of biotin can cross them easily.

What Happens When Interference Is Suspected After the Fact

Sometimes the interference isn’t caught until after blood has already been drawn and results look strange. Labs do have a workaround: they can treat the blood sample with streptavidin-coated microparticles, which mop up the excess biotin before the sample is re-tested. This approach has been validated and shown to restore normal results even in samples from patients taking 300 milligrams of biotin daily for multiple sclerosis treatment.¹⁶ The technique works for both competitive and sandwich immunoassays and, critically, doesn’t change the sample volume, so it remains valid for free thyroid hormone measurements.

This isn’t something labs do routinely on every sample. It’s a remediation step taken when clinicians suspect biotin interference and request it. The easier path for you as a patient is to simply stop biotin ahead of time and avoid the problem altogether.

How Misdiagnosis Actually Happens

The clinical danger isn’t abstract. A patient with progressive multiple sclerosis taking high-dose biotin was found to have what appeared to be extremely elevated free T4, elevated T3, and suppressed TSH. Every assay that yielded abnormal results happened to use the biotin-streptavidin linkage.¹⁷ Without awareness of biotin interference, that pattern leads straight to a Graves’ disease workup, potentially including radioactive iodine treatment or antithyroid drugs, neither of which would be appropriate for someone whose thyroid is actually fine.

This interference has led to many misdiagnoses in clinical practice, with potential for unnecessary additional testing and sometimes the initiation of inappropriate or potentially harmful treatment.⁵ The frustrating part is that the fix is simple: ask about supplements before drawing blood, and hold biotin for the recommended period. Yet awareness among clinicians and patients is still inconsistent.

Practical Steps Worth Taking

If you take any biotin supplement and have a thyroid test scheduled, stop the supplement at least 48 hours before your blood draw. If you take more than 5 milligrams daily, consider stopping for a full week. If you have kidney disease, err toward the longer washout and make sure your doctor knows about the supplement.

It’s also worth knowing that biotin shows up in unexpected places. Many multivitamins, prenatal vitamins, and B-complex supplements contain biotin, sometimes without prominently listing it on the front label. Check the back panel or full ingredient list of anything you take regularly. Some energy drinks and “beauty” supplements contain biotin as well. If you mention biotin to your doctor, you might want to bring the actual bottles so you can confirm the doses together.

You generally can’t find out what assay platform your lab uses without asking directly. If you’re concerned and unable to stop biotin (for instance, if it’s prescribed for a neurological condition), raise the issue with your doctor so they can request that the lab either use a non-biotin-streptavidin platform or apply the streptavidin-microparticle depletion step to your sample before testing. These options exist and work, but someone has to ask for them.

Biotin in Multiple Sclerosis Treatment

The patients at greatest risk for severe interference are those taking high-dose biotin as a treatment for progressive multiple sclerosis. These doses can reach 300 milligrams per day, which is roughly 10,000 times the recommended daily intake.⁶ At those levels, blood biotin concentrations can be astronomically high, and the two-day washout recommended for standard supplement users is almost certainly insufficient.

For these patients, coordination between their neurologist and any other physician ordering blood work is essential. The lab tests most commonly affected in this group, free T4, TSH, and troponin, happen to be among the most clinically important and commonly ordered. The mismatch between how alarming the fake numbers can look and how straightforward the solution is (just hold the supplement longer or treat the sample) makes this a problem where awareness does almost all the heavy lifting.

1
JAMA. Association of Biotin Ingestion With Performance of Hormone and Nonhormone Assays in Healthy Adults
2
PubMed Central. How Biotin Induces Misleading Results in Thyroid Bioassays: Case Series
3
PubMed Central. High-Dose Biotin Treatment for Secondary Progressive Multiple Sclerosis May Interfere with Thyroid Assays
4
PubMed. Prevalence of biotin supplement usage in outpatients and plasma biotin concentrations in patients presenting to the emergency department
5
PubMed Central. Good For Hair, Skin, And Nails But Bad For Thyroid Lab Tests
6
PubMed Central. Effect of High-dose Biotin on Thyroid Function Tests: Case Report and Literature Review
7
PubMed Central. When thyroid labs do not add up, physicians should ask patients about biotin supplements
8
PubMed Central. The clinical significance of low dose biotin supplements (<300μg/day) in the treatment of patients with hypothyroidism: crucial or overestimated?
9
PubMed. Chronic kidney failure and biotin: A combination inducing unusual results in thyroid and parathyroid investigations, report of 2 cases
10
PubMed. Comprehensive assessment of biotin interference in immunoassays
11
PubMed Central. Assessment of biotin interference in thyroid function tests
12
The Journal of Clinical Endocrinology & Metabolism. Factitious Graves’ Disease Due to Biotin Immunoassay Interference—A Case and Review of the Literature
13
The Journal of Applied Laboratory Medicine. Biotin Interference in Clinical Immunoassays
14
PubMed. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing
15
Annals of Clinical & Laboratory Science. Significant Interference of Biotin in Thyroid Function Tests Using Beckman Analyzer: How to Identify such Interferences?
16
PubMed. Depletion of biotin using streptavidin-coated microparticles: a validated solution to the problem of biotin interference in streptavidin-biotin immunoassays
17
PubMed. Misdiagnosis of Graves’ Disease with Apparent Severe Hyperthyroidism in a Patient Taking Biotin Megadoses